CRP and rheumatoid arthritis: RA patients were older, had more comorbidities and received etanercept less often as monotherapy, while disease activity indices (DAS28-ESR and ASDAS-CRP) as well as patients’ perception of disease activity status (VAS global) were high and comparable between RA and SpA.